Poehling Capital Management INC. Makes New Investment in Lam Research Corporation $LRCX

Poehling Capital Management INC. purchased a new stake in Lam Research Corporation (NASDAQ:LRCX) in the 2nd quarter, HoldingsChannel.com reports. The institutional investor purchased 3,300 shares of the semiconductor company’s stock, valued at approximately $1,430,000.

Several other large investors have also recently modified their holdings of LRCX. Fideuram Asset Management Ireland dac bought a new position in shares of Lam Research during the 4th quarter worth approximately $10,035,000. Generali Investments Management Co LLC increased its stake in shares of Lam Research by 62.0% in the 4th quarter. Generali Investments Management Co LLC now owns 36,274 shares of the semiconductor company’s stock valued at $6,209,000 after acquiring an additional 13,878 shares in the last quarter. Rokos Capital Management LLP lifted its position in shares of Lam Research by 42.0% during the 1st quarter. Rokos Capital Management LLP now owns 259,921 shares of the semiconductor company’s stock valued at $55,532,000 after acquiring an additional 76,840 shares during the period. Aware Super Pty Ltd as trustee of Aware Super acquired a new position in shares of Lam Research during the 1st quarter valued at $59,973,000. Finally, Y Intercept Hong Kong Ltd bought a new position in Lam Research during the first quarter worth $26,489,000. Institutional investors own 84.61% of the company’s stock.

Insider Buying and Selling

In other Lam Research news, Director Abhijit Y. Talwalkar sold 18,282 shares of the firm’s stock in a transaction on Monday, July 13th. The stock was sold at an average price of $335.00, for a total transaction of $6,124,470.00. Following the transaction, the director directly owned 87,142 shares in the company, valued at approximately $29,192,570. This trade represents a 17.34% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Neil J. Fernandes sold 7,659 shares of Lam Research stock in a transaction on Monday, June 1st. The stock was sold at an average price of $309.60, for a total transaction of $2,371,226.40. Following the transaction, the senior vice president directly owned 58,470 shares in the company, valued at $18,102,312. This represents a 11.58% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 80,441 shares of company stock worth $27,614,296. 0.31% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on LRCX shares. BNP Paribas Exane raised their price target on shares of Lam Research from $250.00 to $260.00 and gave the stock a “neutral” rating in a report on Thursday, April 23rd. Weiss Ratings cut shares of Lam Research from a “buy (b)” rating to a “buy (b-)” rating in a research report on Friday, August 7th. Morgan Stanley reduced their target price on Lam Research from $404.00 to $367.00 and set an “overweight” rating for the company in a research note on Thursday, July 30th. Berenberg Bank boosted their target price on Lam Research from $265.00 to $335.00 and gave the company a “buy” rating in a research report on Thursday, April 23rd. Finally, Jefferies Financial Group set a $335.00 price target on Lam Research and gave the stock a “buy” rating in a report on Thursday, July 30th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-six have issued a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $358.47.

Lam Research Price Performance

LRCX stock opened at $327.92 on Wednesday. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.91 and a current ratio of 2.63. The business has a 50-day simple moving average of $339.86 and a two-hundred day simple moving average of $284.93. The company has a market capitalization of $410.33 billion, a P/E ratio of 56.93, a price-to-earnings-growth ratio of 1.32 and a beta of 1.84. Lam Research Corporation has a 52-week low of $94.11 and a 52-week high of $438.50.

Lam Research (NASDAQ:LRCX) last issued its quarterly earnings data on Wednesday, July 29th. The semiconductor company reported $1.82 EPS for the quarter, topping the consensus estimate of $1.69 by $0.13. Lam Research had a return on equity of 67.60% and a net margin of 31.27%.The firm had revenue of $6.72 billion during the quarter, compared to the consensus estimate of $6.66 billion. During the same period in the prior year, the business posted $1.33 earnings per share. The company’s quarterly revenue was up 30.0% compared to the same quarter last year. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. Research analysts expect that Lam Research Corporation will post 9.32 EPS for the current fiscal year.

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.